Sonodynamic Therapy Complements PD-L1 Immune Checkpoint Inhibition in a Murine Model of Pancreatic Cancer

被引：0

作者：

Nesbitt, Heather ^{[1
]}

Logan, Keiran ^{[1
]}

Thomas, Keith ^{[1
]}

Callan, Bridgeen ^{[1
]}

Gao, Jinhui ^{[1
]}

Mc Kaig, Thomas ^{[1
]}

Taylor, Mark ^{[2
]}

Love, Mark ^{[3
]}

Stride, Eleanor ^{[4
]}

Mc Hale, Anthony ^{[1
]}

Callan, John ^{[1
]}

机构：

[1] Ulster Univ, Coleraine, Londonderry, North Ireland

[2] Mater Hosp, Belfast, Antrim, North Ireland

[3] Royal Victoria Hosp, Belfast, Antrim, North Ireland

[4] Univ Oxford, Oxford, England

来源：

BRITISH JOURNAL OF SURGERY | 2021年 / 108卷

关键词：

D O I：

暂无

中图分类号：

R61 [外科手术学];

学科分类号：

摘要：

O-P04

引用

页数：2

共 50 条

[11] Predictive biomarkers for PD-1 and PD-L1 immune checkpoint blockade therapy
Song, Yue
Li, Zhaoming
Xue, Weili
Zhang, Mingzhi
IMMUNOTHERAPY, 2019, 11 (06) : 515 - 529
[12] OPTIMIZING SEQUENCE OF THERAPY AND RADIATION DELIVERY WHEN COMBINED WITH PD-L1 IMMUNE-CHECKPOINT INHIBITION IN BLADDER CANCER
Tholomier, Come
Marcq, Gautier
Shinde-Jadhav, Surashri
Ayoub, Mina
Huang, Jia Ming
Kool, Ronald
Skowronski, Rodrigo
Mansure, Jose Joao
Kassouf, Wassim
JOURNAL OF UROLOGY, 2020, 203 : E827 - E828
[13] Olaparib enhances radiation-induced Type I interferon and sensitizes pancreatic cancer to PD-L1 immune checkpoint inhibition
Valvo, Victoria M.
Zhang, Qiang
Jiang, Long
Tate, Ashkay
Green, Michael D.
Morgan, Meredith A.
MOLECULAR CANCER THERAPEUTICS, 2023, 22 (12)
[14] Immunohistochemistry of Immune Checkpoint Markers PD-1 and PD-L1 in Prostate Cancer
Sharma, Meenal
Yang, Qi
Mcmahon, Loralee
Miyamoto, Hiroshi
MODERN PATHOLOGY, 2019, 32
[15] Safety and Tolerability of Immune Checkpoint Inhibitors (PD-1 and PD-L1) in Cancer
Iosune Baraibar
Ignacio Melero
Mariano Ponz-Sarvise
Eduardo Castanon
Drug Safety, 2019, 42 : 281 - 294
[16] Immunohistochemistry of Immune Checkpoint Markers PD-1 and PD-L1 in Prostate Cancer
Sharma, Meenal
Yang, Qi
Mcmahon, Loralee
Miyamoto, Hiroshi
LABORATORY INVESTIGATION, 2019, 99
[17] PD-1/PD-L1 IMMUNE-CHECKPOINT INHIBITION WITH RADIATION IN BLADDER CANCER: IN SITU AND ABSCOPAL EFFECTS
Rompre-Brodeur, Alexis
Ayoub, Mina
Shinde-Jadhav, Surashri
Piccirillo, Ciriaco
Seuntjens, Jan
Brimo, Fadi
Mansure, Jose Joao
Kassouf, Wassim
JOURNAL OF UROLOGY, 2019, 201 (04): : E817 - E817
[18] PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, Andreas D.
Taran, Florin-Andrei
Wallwiener, Markus
Walter, Christina B.
Kraemer, Bernhard
Grischke, Eva-Maria
Brucker, Sara Y.
BREAST CARE, 2016, 11 (06) : 385 - 390
[19] Safety and Tolerability of Immune Checkpoint Inhibitors (PD-1 and PD-L1) in Cancer
Baraibar, Iosune
Melero, Ignacio
Ponz-Sarvise, Mariano
Castanon, Eduardo
DRUG SAFETY, 2019, 42 (02) : 281 - 294
[20] Immunohistochemistry of immune checkpoint markers PD-1 and PD-L1 in prostate cancer
Sharma, Meenal
Yang, Zhiming
Miyamoto, Hiroshi
MEDICINE, 2019, 98 (38)

← 1 2 3 4 5 →